MEAN PLATELET VOLUME AND DISTRIBUTION WIDTH IN TYPE II DIABETES
Abstract
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic illness characterized by persistent hyperglycemia, which raises the chance of macrovascular and microvascular complications. These issues are linked to increased platelet activation, aggregation, and thromboxane production.
Objective: This study sought to assess the use of Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW) as possible hematologic indicators for detecting vascular complications in people with T2DM.
Methods: A retrospective cross-sectional research was conducted using the medical records of 141 T2DM patients treated at Sanjiwani Gianyar Hospital in 2023. Patients were split into two groups based on the presence or absence of vascular complications such as coronary artery disease, cerebrovascular disease, peripheral arterial disease, diabetic nephropathy, and diabetic retinopathy. MPV and PDW values were derived from routine Complete Blood Count (CBC) testing. The data were tested for normality, and any changes between groups were calculated using an independent samples t-test.
Results: Patients with vascular complications had significantly higher MPV values (9.53 ± 1.30 fL) than those without complications (8.99 ± 0.96 fL), with a statistically significant p-value of 0. 018. However, the two groups' PDW values did not differ significantly (15.95 ± 0.44 vs. 15.91 ± 0.36; p = 0.582).
Conclusions: MPV may be a useful and cost-effective hematological parameter associated with vascular complications in T2DM patients, but the clinical relevance of PDW is unclear and requires more research.
Full Text:
PDFReferences
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol [Internet]. 2018;14(2):88–98. Available from: http://dx.doi.org/10.1038/nrendo.2017.151
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract [Internet]. 2019;157:107843. Available from: https://doi.org/10.1016/j.diabres.2019.107843
Soeatmadji DW, Rosandi R, Saraswati MR, Sibarani RP, Tarigan WO. Clinicodemographic Profile and Outcomes of Type 2 Diabetes Mellitus in the Indonesian Cohort of DISCOVER: A 3-Year Prospective Cohort Study. J ASEAN Fed Endocr Soc. 2023;38(1):68–74.
Zaman W, Amin A. Mechanistic Insight into Phenolic Compounds in Mitigating Diabetic Complications Induced by Advanced Glycation End Products. Curr Issues Mol Biol. 2025;47(10).
Huang Y, Yue L, Qiu J, Gao M, Liu S, Wang J. Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability. Horm Metab Res. 2022;54(7):419–28.
Yang DR, Wang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne). 2024;15(April):1–21.
Khanna P, Salwan SK, Sharma A. Correlation of Platelet Indices in Patients With Type 2 Diabetes Mellitus and Associated Microvascular Complications: A Hospital-Based, Prospective, Case-Control Study. Cureus. 2024;16(3).
Le TN, Bright R, Truong VK, Li J, Juneja R, Vasilev K. Key biomarkers in type 2 diabetes patients: A systematic review. Diabetes, Obes Metab. 2025;27(1):7–22.
Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): New perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019;2019.
Nakhro N, Khambra P, Sharma S, T. Banikanta Singha. Metabolic consequences on platelet parameters: Mean platelet volume and platelet distribution width in type 2 diabetes mellitus. Asian J Med Sci. 2024;15(10):45–50.
Wei Y, Lin Y, Huang L, Wang C, Li R. Association between mean platelet volume and the risk of type 2 diabetes mellitus among women with history of gestational diabetes mellitus. BMC Endocr Disord [Internet]. 2024;24(1). Available from: https://doi.org/10.1186/s12902-024-01693-3
Riset Kesehatan Dasar (Riskesdas). Laporan Riskesdas 2018 Nasional.pdf [Internet]. Lembaga Penerbit Balitbangkes. 2018. p. hal 156. Available from: https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf
Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46(January):S19–40.
Tariket S, Hamzeh-Cognasse H, Laradi S, Arthaud CA, Eyraud MA, Bourlet T, et al. Evidence of CD40L/CD40 pathway involvement in experimental transfusion-related acute lung injury. Sci Rep. 2019;9(1):1–12.
Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.
Joshi AA, Jaison J. The Study of Platelet Parameters- Mean Platelet Volume (MPV) and Platelet Distribution Width (PDW) in Type 2 Diabetes Mellitus. Ann Pathol Lab Med. 2019;6(8):A407-413.
Siddiqui NA, Narang S, Aggarwal A, Gupta R, Goel V. Immature Platelet Fraction and Other Platelet Indices in Type 2 Diabetes Mellitus. Cureus. 2025;17(2).
Aktas F, Aktuglu MB. Evaluation of the relation between HBA1C and MPV, PDW levels of patients with Type 2 diabetes admitted in internal medicine polyclinics. North Clin Istanbul. 2023;10(5):681–6.
City A, Nouraldein M, Hamad M, Jalalaldeen AH, Hamid AA, Awad DM, et al. Reviews & Reports Evaluation of Platelet Indices in Patients with Type 2 Diabetes Mellitus. 6(6):1–4.
Agarwal A, Arya A, Saxena RS, Dube S. Mean Platelet Volume in Type 2 Diabetes: Correlation with Poor Glycaemic Control. EMJ Diabetes. 2023;i(November):85–91.
Jena S, Raizada N, Kalra S, Bhattacharya S. Platelet Indices as Predictors of Glycaemic Status and Complications in Diabetes Mellitus. Apollo Med. 2025;22(3):214–9.
Cassano V, Armentaro G, Iembo D, Miceli S, Fiorentino T V., Succurro E, et al. Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis: Platelets in cardiovascular risk. Cardiovasc Diabetol. 2024;23(1):1–10.
Shilpi K, Potekar RM. A Study of Platelet Indices in Type 2 Diabetes Mellitus Patients. Indian J Hematol Blood Transfus. 2018;34(1):115–20.
Handtke S, Thiele T. Large and small platelets—(When) do they differ? J Thromb Haemost [Internet]. 2020;18(6):1256–67. Available from: https://doi.org/10.1111/jth.14788
Brahmbhatt KJ, Chaudhary B, Raval DM, Mallik S, Khan S, Patel M, et al. Association of Mean Platelet Volume With Vascular Complications in the Patients With Type 2 Diabetes Mellitus. Cureus. 2022;14(9).
DOI: https://doi.org/10.33992/meditory.v13i2.4278
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Ayu Pradnyadari

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.






_page-00019.jpg)
_page-00018.jpg)
_page-00011.jpg)
